Harry E. Carmitchel, Chief Operating Officer at OSIRIS THERAPEUTICS, INC. (OSIR), sold 7,000 shares at $19.46 ($136K) on 2008-12-08, disclosed to the SEC on 2008-12-10.
Open-market sale of $136k OSIR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.